Microvillus Inclusion Disease
1 clinical trials · Condition
◉ Watch Microvillus Inclusion Disease
| Record | Firm | Date |
|---|---|---|
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) (NCT06721871) | Napo Pharmaceuticals, Inc. | 2025-05-01 |
Track Microvillus Inclusion Disease automatically
Every clearance here is in the API, with alerts when new ones post.